The FDA has received reports of immune effector cell-associated enterocolitis (IEC-EC) in patients who received treatment with CARVYKTI.
Similar Posts
CDL Services, Inc. DBA Technichem – 713877 – 11/24/2025
CGMP/Finished Pharmaceuticals/AdulteratedNatural MiracleZEN GOLD 60000 contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Natural MiracleZEN GOLD 60000, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.Maria A. Carballosa, M.D. – 720805 – 12/12/2025
In Vivo Bioavailability-Bioequivalence Studies – ClinicalEnviroServe Chemicals & Cleaners Ltd. – 674090 – 09/09/2024
CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/MisbrandedFDA In Brief: FDA provides guidance on improving the agency’s interactions with product developers to make the drug development process more informed and efficient
FDA announces two new guidances to support enhanced communication with drug developers, help make the development process more informed and efficientBaxter Oncology GmbH – 08/27/2024
Baxter Oncology GmbH – 08/27/2024. Country: Germany. Record Type: 483
